{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T15:03:43Z","timestamp":1792854223996,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T00:00:00Z","timestamp":1660089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T00:00:00Z","timestamp":1660089600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"a National Research Foundation of Korea grant funded by the Korean Government","award":["NRF-2021R1I1A3056129"],"award-info":[{"award-number":["NRF-2021R1I1A3056129"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    To evaluate the prognosis of non-small cell lung cancer (NSCLC) patients according to endobronchial metastatic lesion (EML), especially those not identified on positron emission tomography or computed tomography. We evaluated progression-free survival (PFS) and overall survival (OS) according to the presence of EML in patients with NSCLC who were diagnosed at a tertiary hospital between January 2010 and December 2019. A total of 364 patients were enrolled in this study. EML was found in 69 (19.0%) patients with NSCLC. In the patients with EML versus the patients without EML, median PFS was 7.0 (3.5\u201313.5) and 9.5 (5.5\u201317.5) months (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.011), and median OS was 12.0 (6.0\u201330.0) versus 20.0 (10.0\u201339.0) months (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.016), respectively. Median PFS and OS rates were highest in epidermal growth factor receptor (EGFR) (+) and EML (\u2212) patients and lowest in EGFR (\u2212) and EML (+) patients (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009&lt;\u20090.001). By multivariate cox regression analysis, PFS in overall patients with NSCLC was significantly associated with EML, EGFR mutation, performance status, and pleural effusion. NSCLC patients with EML had worse prognoses of PFS and OS than patients without EML.\n                  <\/jats:p>","DOI":"10.1038\/s41598-022-17918-1","type":"journal-article","created":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T06:02:59Z","timestamp":1660111379000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["The prognosis of non-small cell lung cancer patients according to endobronchial metastatic lesion"],"prefix":"10.1038","volume":"12","author":[{"given":"Yoonki","family":"Hong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunmin","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2450-4882","authenticated-orcid":false,"given":"Myoung Kyu","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,10]]},"reference":[{"issue":"2","key":"17918_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"A Jemal","year":"2011","unstructured":"Jemal, A. et al. Global cancer statistics. CA Cancer J Clin 61(2), 69\u201390 (2011).","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"17918_CR2","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1378\/chest.123.2.333","volume":"123","author":"GA Silvestri","year":"2003","unstructured":"Silvestri, G. A., Hoffman, B. & Reed, C. E. One from column A: choosing between CT, positron emission tomography, endoscopic ultrasound with fine-needle aspiration, transbronchial needle aspiration, thoracoscopy, mediastinoscopy, and mediastinotomy for staging lung cancer. Chest 123(2), 333\u2013335 (2003).","journal-title":"Chest"},{"issue":"suppl 4","key":"17918_CR3","first-page":"S359","volume":"5","author":"B Zaric","year":"2013","unstructured":"Zaric, B. et al. Advanced bronchoscopic techniques in diagnosis and staging of lung cancer. J Thorac Dis 5(suppl 4), S359\u2013S370 (2013).","journal-title":"J Thorac Dis"},{"issue":"5","key":"17918_CR4","doi-asserted-by":"publisher","first-page":"640","DOI":"10.6004\/jnccn.2017.0065","volume":"15","author":"AD Lerner","year":"2017","unstructured":"Lerner, A. D. & Feller-Kopman, D. Bronchoscopic techniques used in the diagnosis and staging of lung cancer. J Natl Compr Canc Netw 15(5), 640\u2013647 (2017).","journal-title":"J Natl Compr Canc Netw"},{"issue":"3","key":"17918_CR5","doi-asserted-by":"publisher","first-page":"171","DOI":"10.4103\/2278-330X.114142","volume":"2","author":"P Sharma","year":"2013","unstructured":"Sharma, P., Singh, H., Basu, S. & Kumar, R. Positron emission tomography-computed tomography in the management of lung cancer: an update. South Asian J Cancer 2(3), 171\u2013178 (2013).","journal-title":"South Asian J Cancer"},{"key":"17918_CR6","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/j.ejrad.2011.03.020","volume":"81","author":"V Ambrosini","year":"2012","unstructured":"Ambrosini, V. et al. PET\/CT imaging in different types of lung cancer: an overview. Eur J Radiol 81, 988\u20131001 (2012).","journal-title":"Eur J Radiol"},{"key":"17918_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2012.00208","author":"J Cuaron","year":"2013","unstructured":"Cuaron, J., Dunphy, M. & Rimner, A. Role of FDG-PET scans in staging, response assessment, and follow-up care for non-small cell lung cancer. Front Oncol https:\/\/doi.org\/10.3389\/fonc.2012.00208 (2013).","journal-title":"Front Oncol"},{"issue":"Spec No A","key":"17918_CR8","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1102\/1470-7330.2008.9006","volume":"8","author":"S Rankin","year":"2008","unstructured":"Rankin, S. PET\/CT for staging and monitoring non-small cell lung cancer. Cancer Imaging 8(Spec No A), S27\u2013S31 (2008).","journal-title":"Cancer Imaging"},{"issue":"3","key":"17918_CR9","first-page":"181","volume":"36","author":"N Gupta","year":"2019","unstructured":"Gupta, N. Endobronchial metastasis: the challenge continues. Lung India 36(3), 181\u2013182 (2019).","journal-title":"Lung India"},{"issue":"1","key":"17918_CR10","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.chest.2016.10.010","volume":"15","author":"FC Detterbeck","year":"2017","unstructured":"Detterbeck, F. C., Boffa, D. J., Kim, A. W. & Tanoue, L. T. The eighth edition lung cancer stage classification. Chest 15(1), 193\u2013203 (2017).","journal-title":"Chest"},{"issue":"3","key":"17918_CR11","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1590\/S1806-37132015000004479","volume":"41","author":"B Hochhegger","year":"2015","unstructured":"Hochhegger, B. et al. PET\/CT imaging in lung cancer: indications and findings. J Bras Pneumol 41(3), 264\u2013274 (2015).","journal-title":"J Bras Pneumol"},{"issue":"5","key":"17918_CR12","doi-asserted-by":"publisher","first-page":"e142S","DOI":"10.1378\/chest.12-2353","volume":"143","author":"MP Rivera","year":"2013","unstructured":"Rivera, M. P., Mehta, A. C. & Wahidi, M. M. Establishing the diagnosis of lung cancer: diagnosis and management of lung cancer, 3rd edn.: american college of chest physicians evidence-based clinical practice guidelines. Chest 143(5), e142S-e165S (2013).","journal-title":"Chest"},{"issue":"2","key":"17918_CR13","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1136\/jclinpath-2012-201194","volume":"66","author":"G Ellison","year":"2013","unstructured":"Ellison, G. et al. EGFR mutation testing in lung cancer: a review of available methods and their use for analysis of tumour tissue and cytology samples. J Clin Pathol 66(2), 79\u201389 (2013).","journal-title":"J Clin Pathol"},{"issue":"5","key":"17918_CR14","doi-asserted-by":"publisher","first-page":"515","DOI":"10.6004\/jnccn.2015.0071","volume":"13","author":"DS Ettinger","year":"2015","unstructured":"Ettinger, D. S. et al. Non\u2013small cell lung cancer, version 6.2015. J Natl Compr Canc Netw 13(5), 515\u2013524 (2015).","journal-title":"J Natl Compr Canc Netw"},{"issue":"suppl 5","key":"17918_CR15","doi-asserted-by":"publisher","first-page":"v1","DOI":"10.1093\/annonc\/mdw326","volume":"27","author":"S Novello","year":"2016","unstructured":"Novello, S. et al. Metastatic non-small-cell lung cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 27(suppl 5), v1\u2013v27 (2016).","journal-title":"Ann Oncol"},{"key":"17918_CR16","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1001\/archinte.1975.00330040055008","volume":"135","author":"SS Braman","year":"1975","unstructured":"Braman, S. S. & Whitcomb, M. E. Endobronchial metastasis. Arch Intern Med 135, 543\u2013547 (1975).","journal-title":"Arch Intern Med"},{"issue":"5","key":"17918_CR17","doi-asserted-by":"publisher","first-page":"e135","DOI":"10.1016\/j.athoracsur.2013.09.064","volume":"97","author":"Z Zhang","year":"2014","unstructured":"Zhang, Z. et al. Endotracheal and endobronchial metastases in a patient with stage I lung adenocarcinoma. Ann Thorac Surg 97(5), e135\u2013e137 (2014).","journal-title":"Ann Thorac Surg"},{"key":"17918_CR18","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.lungcan.2012.11.010","volume":"79","author":"HK Ahn","year":"2013","unstructured":"Ahn, H. K. et al. Epidermal growth factor receptor mutation and treatment outcome of mediastinoscopic N2 positive non-small cell lung cancer patients treated with neoadjuvant chemoradiotherapy followed by surgery. Lung Cancer 79, 300\u2013306 (2013).","journal-title":"Lung Cancer"},{"issue":"2","key":"17918_CR19","doi-asserted-by":"publisher","first-page":"493","DOI":"10.4143\/crt.2018.125","volume":"51","author":"SE Park","year":"2019","unstructured":"Park, S. E. et al. EGFR mutation is associated with short progression-free survival in patients with stage III non-squamous cell lung cancer treated with concurrent chemoradiotherapy. Cancer Res Treat 51(2), 493\u2013501 (2019).","journal-title":"Cancer Res Treat"},{"issue":"1","key":"17918_CR20","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1080\/02841860310018053","volume":"43","author":"JB S\u00f8rensen","year":"2004","unstructured":"S\u00f8rensen, J. B. Endobronchial metastases from extrapulmonary solid tumors. Acta Oncol 43(1), 73\u201379 (2004).","journal-title":"Acta Oncol"},{"issue":"3","key":"17918_CR21","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1378\/chest.119.3.768","volume":"119","author":"T Kiryu","year":"2001","unstructured":"Kiryu, T. et al. Endotracheal\/endobronchial metastases: clinicopathologic study with special reference to developmental modes. Chest 119(3), 768\u2013775 (2001).","journal-title":"Chest"},{"key":"17918_CR22","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.resinv.2015.09.001","volume":"54","author":"L Dalar","year":"2016","unstructured":"Dalar, L., \u00d6zdemir, C., S\u00f6k\u00fcc\u00fc, S. N., Karasulu, L. & Alt\u0131n, S. Bronchoscopic palliation to treat endobronchial metastasis of the tracheobronchial tree. Respir Investig 54, 116\u2013120 (2016).","journal-title":"Respir Investig"},{"issue":"4","key":"17918_CR23","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3348\/kjr.2002.3.4.229","volume":"3","author":"NJ Han","year":"2002","unstructured":"Han, N. J. et al. Superficial endobronchial lung cancer: radiologic-pathologic correlation. Korean J Radiol 3(4), 229\u2013234 (2002).","journal-title":"Korean J Radiol"},{"issue":"6","key":"17918_CR24","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s13244-010-0062-3","volume":"2","author":"NM Long","year":"2011","unstructured":"Long, N. M. & Smith, C. S. Causes and imaging features of false positives and false negatives on F-PET\/CT in oncologic imaging. Insights Imaging 2(6), 679\u2013698 (2011).","journal-title":"Insights Imaging"},{"issue":"3","key":"17918_CR25","doi-asserted-by":"publisher","first-page":"178S","DOI":"10.1378\/chest.07-1360","volume":"132","author":"GA Silvestri","year":"2007","unstructured":"Silvestri, G. A. et al. Noninvasive staging of non-small cell lung cancer: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest 132(3), 178S-201S (2007).","journal-title":"Chest"},{"issue":"2","key":"17918_CR26","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.lungcan.2012.10.018","volume":"79","author":"S Iwano","year":"2013","unstructured":"Iwano, S., Ito, S., Tsuchiya, K., Kato, K. & Naganawa, S. What causes false-negative PET findings for solid-type lung cancer?. Lung Cancer 79(2), 132\u2013136 (2013).","journal-title":"Lung Cancer"},{"issue":"5","key":"17918_CR27","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1200\/JCO.1986.4.5.702","volume":"4","author":"DM Finkelstein","year":"1986","unstructured":"Finkelstein, D. M., Ettinger, D. S. & Ruckdeschel, J. C. Long-term survivors in metastatic non-small-cell lung cancer: an eastern cooperative oncology group study. J Clin Oncol 4(5), 702\u2013709 (1986).","journal-title":"J Clin Oncol"},{"issue":"3","key":"17918_CR28","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.lungcan.2015.03.020","volume":"88","author":"CP Simmons","year":"2015","unstructured":"Simmons, C. P. et al. Prognosis in advanced lung cancer: a prospective study examining key clinicopathological factors. Lung Cancer 88(3), 304\u2013309 (2015).","journal-title":"Lung Cancer"},{"issue":"10","key":"17918_CR29","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1038\/bjc.2015.356","volume":"113","author":"FC Kuan","year":"2015","unstructured":"Kuan, F. C. et al. Overall survival benefits of first-line EGFR tyrosine kinase inhibitors in EGFR-mutated non-small-cell lung cancers: a systematic review and meta-analysis. Br J Cancer 113(10), 1519\u20131528 (2015).","journal-title":"Br J Cancer"},{"issue":"10","key":"17918_CR30","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1056\/NEJMoa0810699","volume":"361","author":"TS Mok","year":"2009","unstructured":"Mok, T. S. et al. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. N Engl J Med 361(10), 947\u2013957 (2009).","journal-title":"N Engl J Med"},{"issue":"10","key":"17918_CR31","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1097\/JTO.0b013e318267223a","volume":"7","author":"D Morgensztern","year":"2012","unstructured":"Morgensztern, D., Waqar, S., Subramanian, J., Trinkaus, K. & Govindan, R. Prognostic impact of malignant pleural effusion at presentation in patients with metastatic non-small-cell lung cancer. J Thorac Oncol 7(10), 1485\u20131489 (2012).","journal-title":"J Thorac Oncol"},{"key":"17918_CR32","first-page":"1727","volume":"63","author":"BJ Braakhuis","year":"2003","unstructured":"Braakhuis, B. J., Tabor, M. P., Kummer, J. A., Leemans, C. R. & Brakenhoff, R. H. A genetic explanation of Slaughter\u2019s concept of field cancerization: evidence and clinical implications. Cancer Res 63, 1727\u20131730 (2003).","journal-title":"Cancer Res"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-17918-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-17918-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-17918-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T01:53:26Z","timestamp":1669341206000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-17918-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,10]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["17918"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-17918-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,10]]},"assertion":[{"value":"18 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13588"}}